Company
Aridis Pharmaceuticals
Aridis Pharmaceuticals has 6 drugs tracked on RxWires: 2 in Phase 3, 1 in Phase 2, 2 in Phase 1/2, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Suvratoxumab | Phase 3 | Ventilator Associated Pneumonia |
| AR-301 | Phase 3 | Lung Infection |
| AR-105 | Phase 2 | Pseudomonas Aeruginosa Pneumonia |
| KBSA301 | Phase 1/2 | Pneumonia Due to Staphylococcus Aureus |
| Inhaled AR-501 | Phase 1/2 | Cystic Fibrosis |
| Aerucin 2.0mg/kg | Phase 1 | Healthy |
Latest
No recent events.
Follow Aridis Pharmaceuticals on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.